Full Breakdown
Texas Prison System Abruptly Ends Hormone Therapy Policy for Trans Inmates
8/22/2026, 2:57:28 AM
Core Event: Sudden Termination of Policy G-51.11
In July 2026 the Texas Department of Criminal Justice (TDCJ) stopped enforcing Policy G-51.11, which had authorized hormone therapy for incarcerated transgender people.
Background & Context
- 2015 – Policy Introduction: In August 2015 the TDCJ announced Policy G-51.11, allowing all trans inmates to receive hormone therapy, ending a prior “freeze-frame” rule that limited treatment to those already transitioning before incarceration.
- 2019 – Legal Challenge: An incarcerated trans woman sued, claiming denial of gender-affirming surgery violated the Eighth Amendment. The U.S. Supreme Court declined to review the case that December.
- 2025 – Legislative Shift: In August 2025 the state enacted Senate Bill 8, mandating that trans prisoners be housed according to “biological sex.” The law did not repeal Policy G-51.11, which was renewed in July 2026.
- 2026 – Document Removal: Eleven days before the interview, the TDCJ removed the policy text, related consent forms, and a 2014 revision explanation from its online Correctional Managed Health Care (CMHC) Manual, commenting out the HTML code that displayed them. The 2026 Disease Management Guidelines also omitted the “Gender Dysphoria Hormone Monitoring Guideline,” renumbering subsequent entries.
Data & Statistics
- Texas houses an estimated 149,000 inmates, the largest state prison population in the United States.
- In 2019 the TDCJ counted roughly 1,100 transgender inmates, representing about 22 % of the nation’s estimated 5,000 trans prisoners in state facilities (2022 estimate).
- Florida, previously the largest state with a ban on gender-affirming care, holds about 235 trans inmates (2020 estimate).
Official Statements & Responses
- TDCJ: In the phone interview, a TDCJ spokesperson confirmed that Policy G-51.11 “is no longer in effect” and that “no policy is replacing it,” indicating an abrupt cessation of authorized gender-affirming medical services.
- Attorney General Ken Paxton: While not commenting directly on the policy removal, Paxton has previously driven Texas’s bans on driver’s-license gender marker changes and birth-certificate gender markers, actions that align with the timing and nature of the current change.
Why It Matters
The removal makes Texas the sixth state to entirely prohibit gender-affirming care in its prisons. Bans in Georgia and Idaho remain blocked by courts, and Texas is the first to enact such a ban without prior legislation or public notice. Given the size of Texas’s prison system, the policy shift directly affects more than 1,100 incarcerated trans individuals, effectively forcing them to discontinue hormone therapy until release.
Conflicting Reports & Gaps
- Future Replacement: No replacement policy has been announced, and no legislative action has been reported, leaving the status of gender-affirming medical care in Texas prisons uncertain.
Timeline
- August 2015: Policy G-51.11 introduced, permitting hormone therapy for all trans inmates.
- March 29, 2019: Fifth Circuit denies appeal in trans-inmate surgery case (2-1).
- August 2025: Senate Bill 8 mandates housing trans prisoners by biological sex.
- July 2026: Policy G-51.11 renewed.
- July 2026 – early August 2026: Online policy documents removed; “Gender Dysphoria Hormone Monitoring Guideline” deleted from Disease Management Guidelines.
- Mid-August 2026: TDCJ confirms policy is no longer in effect and provides no replacement.
